Department
Pharmaceutical Sciences
Education & Training
- 2004-2008, Doctor of Philosophy (Ph.D.), Integrative Physiology, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia
- 2008-2010, Postdoctoral Fellow, Tulane University, New Orleans, LA, USA
- 2010-2014, Postdoctoral Fellow, Medical College of Wisconsin, Milwaukee, WI, USA
Research & Scholarly Interest
My research focuses on elucidating the molecular, cellular, and physiological mechanisms that drive acute kidney injury (AKI), chronic kidney disease (CKD), and their associated cardiovascular and metabolic complications. By integrating renal physiology, pharmacology, immunology, and vascular biology, I investigate how renal hypoxia, inflammation, fibrosis, immune dysregulation, and aging contribute to disease progression. A central goal of my research program is to identify novel therapeutic targets and develop innovative treatments, including epoxyeicosatrienoic acid (EET)-based therapeutics, soluble epoxide hydrolase inhibitors, hydrogen sulfide–targeted interventions, and other multi-target pharmacological strategies. Through interdisciplinary and translational research, I seek to advance fundamental understanding of kidney disease while accelerating the development of therapies that improve renal and cardiovascular health outcomes.
Honors & Awards
- 2026 : Editors of Distinction Award, BMC Nephrology, Springer Nature, United Kingdom.
- 2020 : Best Oral Abstract Award, Midwest Clinical & Translational Research Meeting, April 2-3, 2020, The Hilton Chicago, Chicago, IL, USA.
- 2018 : Best Oral Abstract Award, Midwest Clinical & Translational Research Meeting, April 26-27, 2018, The Hilton Chicago, Chicago, IL, USA.
- 2014 : Outstanding Presentation Award, 15th International Winter Eicosanoid Conference, March 9-12, 2014, Baltimore, MD, USA.
- 2014 : American Physiological Society Renal Section Research Recognition Award, Experimental Biology 2014, April 26-30, 2014, San Diego, California, USA.
- 2012 : Kidney Council’s New Investigator Award for the HBPR 2012 Scientific Sessions, September 19-22, 2012, Washington D.C., USA.
- 2012 : American Society for Pharmacology and Experimental Therapeutics Drug Discovery, Drug Development & Regulatory Affairs Best Poster Award (First Place), Experimental Biology 2012, April 21-25, 2012, San Diego, California, USA.
- 2012 : Kidney Council’s New Investigator Award for the HBPR 2012 Scientific Sessions, September 19-22, 2012, Washington D.C., USA.
- 2011 : American Society for Pharmacology and Experimental Therapeutics Best Poster Award (Cardiovascular Section), Experimental Biology Meeting 2011, Washington D.C., USA.
- 2011 : Annual High Blood Pressure Research Conference New Investigator Award, High Blood Pressure Research Scientific Sessions 2011, American Heart Association, September 20-24, 2011, Orlando, Florida, USA.